文献速递术前评估与围术期医学

成人非心脏非产科手术后低血压的血管升压药治疗:一项系统评价

Vasopressors to treat postoperative hypotension after adult noncardiac, non-obstetric surgery: a systematic review.
PubMed 文献 · Br J Anaesth · 2023-09-29

该系统评价纳入24项研究(7项RCT、2项前瞻性队列、15项回顾性队列),评估成人非心脏非产科手术后使用血管升压药治疗低血压的使用情况、影响与依据。证据支持有限,未来需明确低血压的驱动机制以合理决策。

要点

  • 术后低血压使用血管升压药的证据质量普遍偏低,仅1项研究为高质量。
  • 接受血管升压药的患者比例中位数为42%(IQR 11.5-74.7%),去甲肾上腺素最常用。
  • 多数研究仅凭临床评估决定干预,血管扩张是最常见的推测生理紊乱。

核心结论

  • 支持使用血管升压药治疗术后低血压的证据有限。
  • 未来研究应关注血管扩张或其他生理紊乱是否为术后低血压的驱动因素,以支持合理决策。

研究设计与样本

  • 前瞻性注册的系统评价,检索Cochrane CENTRAL、EMBASE、MEDBASE和MEDLINE。
  • 纳入成人非心脏非产科手术后接受血管升压药的RCT和队列研究。
  • 共筛选3201篇文章,最终纳入24项研究(7项RCT、2项前瞻性队列、15项回顾性队列)。
  • 由两名研究者进行质量评价,因研究人群和结局异质性大未进行正式Meta分析。

主要发现

  • 1项研究评为高质量,2项为中等质量,其余21项为低质量。
  • 血管扩张是最常见的推测生理紊乱。
  • 接受血管升压药的患者比例中位数为42%(四分位距:11.5-74.7%)。
  • 去甲肾上腺素是最常用的血管升压药。

临床怎么用

  • 临床决策时应认识到支持术后使用血管升压药的证据有限。
  • 需进一步评估低血压的生理机制(如血管扩张)以指导合理用药。

局限性

  • 纳入研究质量普遍偏低,仅1项高质量研究。
  • 研究人群和结局存在显著异质性,无法进行Meta分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postoperative hypotension is common after major surgery and is associated with patient harm. Vasopressors are commonly used to treat hypotension without clear evidence of benefit. We conducted a systematic review to better understand the use, impact, and rationale for vasopressor administration after noncardiac, non-obstetric surgery in adults. METHODS: We conducted a prospectively registered systematic review. Cochrane CENTRAL, EMBASE, MEDBASE, and MEDLINE were searched for RCTs and cohort studies of adult patients receiving vasopressors after noncardiac, non-obstetric surgery. Study quality was critically appraised by two investigators. Findings from the review were synthesised, but formal meta-analysis was not performed because of significant variability in study populations and outcomes. RESULTS: A total of 3201 articles were screened, of which seven RCTs, two prospective cohort studies, and 15 retrospective cohort studies were included in the analysis (24 in total). One study was graded as high quality, two as moderate quality, and the remaining 21 as low quality. Sixteen studies relied on clinical assessment alone to decide on therapeutic interventions. Vasodilation was the most common suggested physiological disturbance. The median proportion of patients receiving vasopressors was 42% (interquartile range: 11.5-74.7%). Norepinephrine was the most common vasopressor used. CONCLUSIONS: The evidence supporting the use of vasopressors to treat postoperative hypotension is limited. Future research should focus on whether vasodilatation or other physiological disturbance is driving postoperative hypotension to allow rational decision-making.

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Douglas N, Leslie K, Darvall JN, et al. Vasopressors to treat postoperative hypotension after adult noncardiac, non-obstetric surgery: a systematic review. Br J Anaesth. 2023. PMID: 37778937. doi:10.1016/j.bja.2023.08.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。